New

ETF model portfolios designed for real investor needs. Discover →

Advertisement
Advertisement
Moving Markets

2023 SPIVA Results: The Good, Bad, and Ugly for Active Management

As usual, passive indexing continues to reign supreme, but active ETFs have pulled ahead in some areas too.

2023 SPIVA Results: The Good, Bad, and Ugly for Active Management

Keep up with what matters in ETFs

Get timely ETF insights, market trends, and top ideas straight to your inbox.

Your newsletter subscriptions with us are subject to ETF Central's Privacy Policy and Terms and Conditions.

The latest edition of the Standard & Poor's Indices Versus Active (SPIVA) report has been released, confirming a trend we've witnessed for years: passive indexing still holds the crown in the investment realm.

A statistic frequently highlighted by analysts is that "87.98% of all U.S. large-cap funds underperformed the S&P 500 Index over the last 15 years," a testament to the challenge of outperforming market benchmarks.

However, it's essential to look beyond the surface. While the broader narrative continues to favor passive strategies, certain areas within the active space are showing promise. The details reveal shifts in some segments where active management is starting to pull ahead.

Let's examine the good, bad, and the ugly for active according to the 2023 SPIVA results, offering insight into where these funds are carving out successes and facing challenges.

Resources

Get data on 14,000+ ETFs

Access Trackinsight's reliable and comprehensive data with 500M+ points on 14,000+ ETFs.

Try for free

The good: small-cap value, fixed income

The latest SPIVA report provides a segmented performance analysis, with large-cap funds, for instance, benchmarked against the S&P 500. However, two segments stood out for their performance.

Firstly, small-cap value, a popular factor combination, showed that over the trailing 1, 3, and 5 years, only 36.84%, 49.32%, and 62.14% of all funds underperformed the S&P SmallCap 600 Value Index, respectively.

My expectation is that underperformance rates may decrease as firms like Avantis Investors and Dimensional Fund Advisors release more cost-efficient factor ETFs, such as the Avantis U.S. Small-Cap Value ETF (

), which has an expense ratio of 0.25%.

The second area where active excelled was in global fixed income. Here, 1, 3, and 5-year underperformance rates against the iBoxx $ Overall Index were low at 31.25%, 32.50%, and 45.45%, respectively.

Fixed income is an area where active management can add significant value due to its less liquid, more opaque nature, and the various levers managers can pull, such as duration and credit quality. An example of success in this field is the PIMCO Active Bond ETF (

), a mainstay in active bond ETFs that has consistently outperformed its index.

Short-term bonds also show promise for narrowing performance gaps, especially as newer active ETFs like the JPMorgan Ultra-Short Income ETF (

) offer competitive expense ratios as low as 0.18%, aligning closely with older index products.

The bad: Large-cap growth

In the SPIVA report, the large-cap growth segment particularly caught my eye. It noted that over the trailing 1-year period, only 9.76% of all funds underperformed the S&P 500 Growth Index. At first glance, this seems impressive. However, the picture changes drastically when you look at the 3-year results, where 72.10% of funds underperformed.

This significant gap can likely be attributed to the recent bull market, driven by the outstanding performance of mega-cap growth stocks. In such an environment, it's easy for the line between genuine skill (alpha) and simply riding the market wave (excess beta exposure) to blur. Funds that heavily overweighted the "magnificent seven" stocks and maintained a focused portfolio generally came out on top.

However, over the long term, factors like drawdowns and volatility play crucial roles. The difference between the one and three-year performance gaps can be traced back to the 2022 bear market, during which many large-cap growth funds faced substantial losses. This highlights the importance of considering longer-term performance and risk management, rather than short-term gains.

The ugly: Large-cap value

The large-cap value segment in the SPIVA report presents a rather ugly picture: funds consistently lagged behind the benchmark across all examined time frames.

The underperformance rates of large-cap value funds against the S&P 500 Value Index were 90.77%, 93.86%, 92.92%, 92.77%, and 93.77% for the 1, 3, 5, 10, and 15-year periods, respectively.

Interestingly, this was one of the few segments where the rate of underperformance did not decrease in shorter time frames, indicating that active managers face difficulties in outperforming the benchmark, regardless of the period analyzed.

This consistent underperformance, both short and long-term, suggests a challenging environment for active management in this space. I think the difficulty in generating alpha in the large-cap value segment can be attributed to its highly scrutinized and crowded nature.

Blue-chip companies like Procter & Gamble and Johnson & Johnson are so extensively covered and analyzed that finding undervalued opportunities is incredibly challenging. Moreover, any potential alpha is likely eroded by management fees, particularly over extended periods.

While large-cap value investing remains a cornerstone of many portfolios, the SPIVA results suggest that indexing might be the more prudent approach in this segment. On the other hand, the small-cap value segment appears to offer more fertile ground for active strategies to outperform, as indicated by the report's findings.

Please note this article is for information purposes only and does not in any way constitute investment advice. It is essential that you seek advice from a registered financial professional prior to making any investment decision.

Advertisement
Advertisement
Advertisement
ETF U
Become a better investor with NYSE: The Home of ETFs
Visit the ETF U homepage
ETF Guides
Advertisement

Recent educational content

Investors Can Fight Healthcare Inflation with Newly Launched ETFs

Asset TV

The ETF Show - Investors Can Fight Healthcare Inflation with Newly Launched ETFs

Adam Schenck, Principal and Managing Director of Fund Services at Milliman joined The ETF Show to discuss Milliman's first ETFs designed to hedge against rising healthcare inflation.

Asset TV
By Asset TV · April 22, 2026
Tidal ETF Industry KPIs

ETF Trends

ETF Industry KPIs April 20, 2026

The ETF Industry saw 14 New Launches, 1 Ticker Change and 16 closures last week.

Tidal
By Tidal · April 22, 2026
The ETF Show - Investors Run to Cash Alternatives as Markets Remain Volatile

Asset TV

The ETF Show - Investors Run to Cash Alternatives as Markets Remain Volatile

Jason England, Portfolio Manager and Fixed Income Strategist from Simplify joined The ETF Show to discuss investor allocations to fixed income as markets continue on their rollercoaster ride.

Asset TV
By Asset TV · April 15, 2026
Tidal ETF Industry KPIs

ETF Trends

ETF Industry KPIs March 30, 2026

The ETF Industry saw 33 New Launches, 1 Ticker Change and 9 closures last week.

Tidal
By Tidal · March 31, 2026

Browse all educational columns

Advertisement
ETF INVESTOR TOOLS

Build and Analyze Your ETF Portfolio Like a Pro

Create your own ETF portfolio in minutes and instantly see allocations, exposures, performance, and risk. Visualize diversification across asset classes, regions, and sectors. Stress-test ideas, compare benchmarks, and refine your strategy with professional-grade analytics.

Portfolio Builder